TipRanks
Blau Farmaceutica SA (BR:BLAU3)
:BLAU3
Brazil Market
BLAU3
Blau Farmaceutica SA
RESEARCH TOOLSreports

Blau Farmaceutica SA (BLAU3) Income Statement

― Followers

Blau Farmaceutica SA Income Statement

Last quarter (Q2 2026), Blau Farmaceutica SA's total revenue was R$486.60M, an increase of 4.68% from the same quarter last year. In Q2, Blau Farmaceutica SA's net income was R$53.39M. See Blau Farmaceutica SA’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
R$ 1.70BR$ 1.75BR$ 1.37BR$ 1.41BR$ 1.37B
Gross Profit
R$ 652.52MR$ 658.75MR$ 490.25MR$ 667.88MR$ 665.93M
Operating Expenses
R$ 322.77MR$ 348.71MR$ 155.16MR$ 217.95MR$ 256.01M
Depreciation and Amortization
R$ 64.34MR$ 51.76MR$ 38.89MR$ 22.29MR$ 20.91M
EBITDA
R$ 394.08MR$ 406.15MR$ 405.23MR$ 523.28MR$ 530.17M
Operating Income
R$ 329.75MR$ 341.80MR$ 211.54MR$ 449.93MR$ 456.87M
Other Income/Expenses
R$ 58.73MR$ -49.91MR$ 122.69MR$ 18.63MR$ 25.59M
Pretax Income
R$ 388.47MR$ 291.89MR$ 334.23MR$ 468.56MR$ 482.47M
Net Income
R$ 294.95MR$ 217.21MR$ 249.81MR$ 363.37MR$ 325.22M
Per Share Metrics
Basic EPS
R$ 0.98R$ 1.22R$ 1.41R$ 2.02R$ 1.81
Diluted EPS
R$ 0.98R$ 1.22R$ 1.41R$ 2.02R$ 1.81
Weighted Average Shares Outstanding
 300.28M 177.68M 177.68M 179.39M 179.39M
Weighted Average Shares Outstanding (Diluted)
 300.28M 177.68M 177.68M 179.39M 179.39M
Currency in BRL

Blau Farmaceutica SA Earnings and Revenue History